The ACME Laboratories Ltd. (DSE:ACMELAB)
77.70
+0.70 (0.91%)
At close: Oct 15, 2026
The ACME Laboratories Market Cap
The ACME Laboratories has a market cap or net worth of 16.44 billion as of October 15, 2026. It is the 23,422nd most valuable company in the world and the 43rd biggest in Bangladesh. Its market cap has increased by 1.97% in one year.
Market Cap
16.44B
Enterprise Value
36.39B
Revenue
40.05B
Global Rank
Country Rank
#43 Bangladesh
PE Ratio
6.17
ChartMarket Cap Chart
Since June 8, 2016, The ACME Laboratories's market cap has decreased from 23.61B to 16.44B, a decrease of -30.38%. That is a compound annual growth rate of -3.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 16.44B | 9.59% |
| Dec 30, 2025 | 15.00B | -5.59% |
| Dec 30, 2024 | 15.89B | -11.65% |
| Dec 28, 2023 | 17.99B | - |
| Dec 29, 2022 | 17.99B | -1.73% |
| Dec 30, 2021 | 18.30B | 15.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 64.42B |
| Renata | 51.09B |
| Unilever Consumer Care | 38.09B |
| Beacon Pharmaceuticals | 23.19B |
| Asiatic Laboratories | 12.64B |
| The IBN SINA Pharmaceutical Industry | 9.64B |
| Navana Pharmaceuticals | 6.67B |
| Orion Pharma | 6.01B |